Journal of General Internal Medicine

, Volume 25, Issue 7, pp 670–674

Effect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/Naloxone

Authors

    • Department of Internal MedicineYale University School of Medicine
    • General Internal MedicineYale University School of Medicine
  • Brent A. Moore
    • Department of PsychiatryYale University School of Medicine
  • Lynn E. Sullivan
    • Department of Internal MedicineYale University School of Medicine
    • General Internal MedicineYale University School of Medicine
  • David A. Fiellin
    • Department of Internal MedicineYale University School of Medicine
    • Investigative Medicine ProgramYale University School of Medicine
    • General Internal MedicineYale University School of Medicine
Original Article

DOI: 10.1007/s11606-010-1306-0

Cite this article as:
Wang, E.A., Moore, B.A., Sullivan, L.E. et al. J GEN INTERN MED (2010) 25: 670. doi:10.1007/s11606-010-1306-0

Abstract

Background

Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known.

Objective

The purpose of this study is to determine whether having a history of incarceration affects response to primary care office-based buprenorphine/naloxone treatment.

Design

In this post hoc secondary analysis of a randomized clinical trial, we compared demographic, clinical characteristics, and treatment outcomes among 166 participants receiving primary care office-based buprenorphine/naloxone treatment stratifying on history of incarceration.

Main Results

Participants with a history of incarceration have similar treatment outcomes with primary care office-based buprenorphine/naloxone than those without a history of incarceration (consecutive weeks of opioid-negative urine samples, 6.2 vs. 5.9, p = 0.43; treatment retention, 38% vs. 46%, p = 0.28).

Conclusions

Prior history of incarceration does not appear to impact primary care office-based treatment of opioid dependence with buprenorphine/naloxone. Community health care providers can be reassured that initiating buprenorphine/naloxone in opioid dependent individuals with a history of incarceration will have similar outcomes as those without this history.

KEY WORDS

buprenorphine/naloxoneincarcerationprimary carejailprison

Copyright information

© Society of General Internal Medicine 2010